Abstract:Dendritic cells play an integral role in the normal physiological function of lymph nodes. They participate in the clonal expansion and evolution of B-cells [1] and induce specific immune responses [2]. In Hodgkin’s lymphoma, the existence of an intact dendritic cell reticulum has been shown to be a positive prognostic indicator in a retrospective Hodgkin’s lymphoma set treated mainly with radiotherapy [3]. The aim of the present study was to explore whether preservation of the denritic cell network could serve as a prognostic indicator also in Hodgkin’s lymphoma patients treated with modern treatment modalities. The series consisted of 63 adult patients (15 – 88 years old) with histologically proven Hodgkin’s lymphoma treated at the Department of Radiotherapy and Oncology, Oulu University Hospital, between January 1990 and December 1997. The patients were diagnosed and staged according to the routine lymphoma staging procedures. Thirty-five patients were treated with either chemotherapy or combined chemoand radiotherapy and 28 patients recieved radiotherapy alone. Paraffin sections were stained for cystatin A using a monoclonal anti-cystatin A antibody (commercially available from Sigma Chemical Co and from Alexis Biochemicals) diluted 1/800 and 1/1600 in PBS containing 1% bovine serum albumin according to methods described earlier [3]. Also sample evaluation and statistical methods followed the previous scheme. In the present study, using a monoclonal cystatin A antibody, we were unable to confirm earlier findings of the prognostic significance of preserved dendritic cell network in Hodgkin’s lymphoma in the whole material. However, when considering patients treated with radiation therapy alone a trend towards worse survival could be detected in patients with a disrupted dendritic cell reticulum, not falling far apart from previous studies. No patients with a preserved dendritic cell reticulum (8 patients) died of Hodgkin’s lymphoma compared to 5 of 20 with a disrupted dendritic cell reticulum. Alavaikko et al. have published a study of 139 Hodgkin’s lymphoma patients treated between the years 1963 and 1989 at our hospital and Tampere University Hospital, and they found a preserved dendritic cell network to be of marked prognostic relevance [3]. Our results are not in line with their findings. However, this new set of patients were all treated in the 1990’s. Between these 2 study periods, there have been remarkable changes in the diagnostic and treatment modalities of Hodgkin’s lymphoma, and survival has been steadily increasing. The most important changes have been the development and wide adoption of new effective chemotherapeutic combinations, such as ABVD and MOPP/ABVD, and the development of highdose treatment with stem cell support for patients with refractory or relapsing disease. These changes may have affected the prognostic importance of the different biological features of the disease. It could be anticipated that, at the time when large-field radiation therapy was the primary treatment modality, the significance of immune response to control the microscopic residual disease outside the treatment field would have been of a major prognostic significance. On the other hand, in patients treated with modern multi-agent chemotherapy regimens, the tumors chemosensitivity is probably a much more significant discriminating factor in prognosis. In fact, we saw a trend toward poorer survival in the patients

Changing Prognostic Role of Preserved Dendritic Cell Reticulum in Hodgkin's Lymphoma

Regulatory features of Candida albicans hemin-induced filamentation

Candida glabrata maintains two HAP1 ohnologs, HAP1A and HAP1B, for distinct roles in ergosterol gene regulation to mediate sterol homeostasis under azole and hypoxic conditions

Converging Roles of the Metal Transporter SMF11 and the Ferric Reductase FRE1 in Iron Homeostasis of Candida albicans

Ferric reductase-related proteins mediate fungal heme acquisition

The adaptive response to iron involves changes in energetic strategies in the pathogen Candida albicans

Candida albicans possess a highly versatile and dynamic high-affinity iron transport system important for its commensal-pathogenic lifestyle

Human Serum Albumin Facilitates Heme-Iron Utilization by Fungi

Hyphae-Specific Genes HGC1, ALS3, HWP1, and ECE1 and Relevant Signaling Pathways in Candida Albicans

Manganese homeostasis modulates fungal virulence and stress tolerance in Candida albicans

Adaptation of Candida albicans to specific host environments by gain-of-function mutations in transcription factors

Knee extensor and knee flexor strength: cross-sectional area ratios in young and elderly men.

Sfp1 and Rtg3 reciprocally modulate carbon source‐conditional stress adaptation in the pathogenic yeast Candida albicans

Time Course of Global Gene Expression Alterations in Candida Albicans During Infection of Hela Cells

Cytochrome oxidase activity in the auditory system of the mouse: A qualitative and quantitative histochemical study

The Iron-Dependent Regulation of the Candida albicans Oxidative Stress Response by the CCAAT-Binding Factor

The Hog1 MAPK substrate governs Candida glabrata -epithelial cell adhesion via the histone H2A variant

Diverse mechanisms control amino acid‐dependent environmental alkalization by Candida albicans

Sef1-Regulated Iron Regulon Responds to Mitochondria-Dependent Iron–Sulfur Cluster Biosynthesis in Candida albicans

Histone-like transcription factor Hfl1p in Candida albicans harmonizes nuclear and mitochondrial genomic network in regulation of energy metabolism and filamentation development

Essential Role of CgErg6p in Maintaining Oxidative Stress Tolerance and Iron Homeostasis in Candida glabrata